Research libraryMOLEKUL / SOURCE RECORD

Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)

Mashin VV, Belova LA, Kotova EY, Dolgova DR, Statenina AP, Belyaeva YK, Dergacheva AS, Israfilova RR · 2023 · Zh Nevrol Psikhiatr Im S S Korsakova 123(12):34-41. PMID 38147380

Uncontrolled human reportEnglish abstractSource linked

This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

Reports clinical changes with Cortexin plus Neuromexol; biomarkers were assessed in smaller comparison subgroups.

Population and setting: CORNELia; 801 patients with chronic cerebral ischemia and cognitive impairment
Evidence type: Uncontrolled human report
Preparation: See the original report; formulation details require verification.
Source language: Russian
Title provenance: Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

Combination treatment does not isolate Cortexin’s contribution.
The biomarker subset is not the full cohort; observational findings do not establish causality.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.17116/jnevro202312312134

Cite and trace this record

Original source: Mashin VV, Belova LA, Kotova EY, Dolgova DR, Statenina AP, Belyaeva YK, Dergacheva AS, Israfilova RR. Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study) Zh Nevrol Psikhiatr Im S S Korsakova 123(12):34-41. PMID 38147380 2023.

Molekul research summary: https://molekul.io/research/bio-38147380. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Cortexin

A tissue-derived preparation with Russian stroke, cognitive, pediatric and other clinical reports. Study designs vary; the independent stroke review is shown alongside favorable original reports. None validates the personal WHOOP diary.

Editorial policy and evidence standards